April 16, 2014 4:19 PM ET


Company Overview of YM BioSciences USA Inc.

Executive Profile

Yehuda Z. Patt M.D.

Co-Principal Investigator of the ETHECC(C) Trial, YM BioSciences USA Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.



Dr. Yehuda Z. Patt, M.D. has been Co-Principal Investigator of the ETHECC(C) trial of Eximias Pharmaceutical Corporation (formerly, YM BioSciences USA Inc.) since April 2004. Dr. Patt is a Professor of Internal Medicine and the Director of Gastrointestinal Oncology Research at the University of New Mexico Cancer Center in Albuquerque, NM. He is a Professor of Medicine at the University of Maryland and Chief of Gastrointestinal Oncology and of Ambulatory care at the Greenebaum ...

Corporate Headquarters

10 Priscilla Lane
Winchester, Massachusetts 01890

United States

Phone: 905-361-9518
Fax: 905-629-4959

Board Members Memberships

There is no Board Members Memberships data available.


Unknown/Other Education
Hebrew University of Jerusalem
Unknown/Other Education
Hebrew University Faculty of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YM BioSciences USA Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.